DaVita Inc. is the parent company of DaVita Kidney Care and HealthCare Partners. DaVita Kidney Care is a provider of kidney care, delivering dialysis services for chronic kidney failure and end stage renal disease primarily in the United States. HealthCare Partners manages and operates medical groups and affiliated physician networks primarily in California, Nevada, New Mexico, Florida, Colorado and Washington. DaVita Inc., formerly known as DaVita HealthCare Partners Inc., is headquartered in Denver, Colorado.
Industry sector: Medical
Sector classification: Miscellaneous health & allied services, not elsewhere classified
Deep Learning based analysis and prediction model for DaVita healthCare Partners Inc. (DVA) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.
Model is in the production pipeline since Oct. 22, 2015.
Market data for DVA model training are being downloaded from the
Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are
accounted for in this model in the form of the historical data coincided with outbreaks and other
global events in the past used to train ML prediction model for DVA.
Model is being retrained on a daily basis.
| Float | 172M |
| P/E | 18.42 |
| Shares Outstanding | 175M |
| % Held by Insiders | 2.10% |
| % Held by Institutions | 85.45% |
| EPS (last reported FY) | $3.32 |
| EPS (last reported Q) | $0.92 |
| EPS, estimated (last reported Q) | $0.91 |
| Total revenues | $11 B |
| Net income | $1 B |